Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2013; 19(45): 8373-8381
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8373
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8373
Table 1 Rescue therapy strategies in drug resistance patients
| DR patients | Rescue therapyprescriptions | HBN DNA after rescue therapy 12 w | |
| < 500 copies/mL (n) | > 500 copies/mL (n) | ||
| LAM | + ADV (n = 6) | 4 | 2 |
| (n = 11) | →ETV + ADV (n = 5) | 3 | 2 |
| ADV | + ETV (n = 5) | 4 | 1 |
| (n = 12) | + LAM (n = 7) | 6 | 1 |
| LDT | + ADV (n = 6) | 4 | 2 |
| (n = 8) | →ETV + ADV (n = 2) | 2 | 0 |
| ETV | + ADV (n = 2) | 2 | 0 |
| (n = 2) | |||
| LAM+ADV | → ETV + ADV | 1 | 1 |
| (n = 2) | (n = 2) | ||
| LDT+ADV | → ETV + ADV | 1 | 0 |
| (n = 1) | (n = 1) | ||
- Citation: Li L, Liu W, Chen YH, Fan CL, Dong PL, Wei FL, Li B, Chen DX, Ding HG. Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study. World J Gastroenterol 2013; 19(45): 8373-8381
- URL: https://www.wjgnet.com/1007-9327/full/v19/i45/8373.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i45.8373